Objective: We report a case in which multiple overlapping low-profile visualized intraluminal support (LVIS) stents were used as monotherapy for ruptured blood blister-like aneurysm (BBA) of the internal carotid artery (ICA).
Case Presentation: A 48-year-old female presented to the emergency room with acute-onset headache. She was alert without neurological deficit with subarachnoid hemorrhage (SAH) Hunt and Kosnik grade I. Emergency angiography revealed a BBA from the supraclinoid ICA. This aneurysm had a small diameter, which makes coil embolization difficult. Therefore, we planned to use multiple overlapping LVIS stents as monotherapy for the ruptured aneurysm. The postoperative course was uneventful without rebleeding. The patient exhibited no neurological deficits on the clinical follow-up at 1 year.
Conclusion: Multiple overlapping LVIS stents as monotherapy is useful for ruptured BBAs of the ICA.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370645 | PMC |
| http://dx.doi.org/10.5797/jnet.cr.2019-0068 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The ELVIS study: Medium and long-term Efficacy of LVIS EVO stent-assisted coil embolisation for unruptured saccular intracranial aneurysms-A tertiary single-centre experience.
J Med Imaging Radiat Oncol
December 2024
Department of Medical Imaging, Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia.
Introduction: The LVIS EVO (MicroVention) is a braided stent designed to assist coil embolisation of intracranial aneurysms. It offers several structural innovations over previous and currently available braided, and laser-cut, stents that are theorised to improve procedural success. This retrospective audit aims to determine the success and complication rates of LVIS EVO-assisted coil embolisation in unruptured saccular aneurysms at a tertiary neurovascular referral centre in Queensland, Australia.
View Article and Find Full Text PDFComment on "Comparison of LVIS and enterprise stent-assisted coiling embolization for ruptured intracranial aneurysms: a propensity score-matched cohort study".
Neurosurg Rev
October 2024
Department of Cariology, Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College and Hospital, Saveetha University, Chennai, Tamil Nadu, 600077, India.
Comparison of LVIS and Enterprise stent-assisted coiling embolization for ruptured intracranial aneurysms: a propensity score-matched cohort study.
Neurosurg Rev
September 2024
Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.
Article Synopsis
- The study compares the safety and efficacy of two stent types, LVIS and Enterprise, in treating ruptured intracranial aneurysms (RIA) using data from 231 patients admitted between 2018 and 2021.
- Before adjusting for other variables, Enterprise showed a higher rate of poor prognosis after 12 months compared to LVIS.
- After thorough analysis, the LVIS group had a significantly lower occurrence of delayed cerebral ischemia (DCI) compared to the Enterprise group, suggesting similar overall efficacy but differing risks for complications.*
Drill turn technique for enhanced visualization of wide-neck bifurcation aneurysms in Y-stent-assisted coiling with LVIS EVO stents: technical considerations and mid-term results.
Neuroradiology
September 2024
Acıbadem Atakent Hospital Radiology Department, Istanbul, 34098, Turkey.
Article Synopsis
- Crossing Y-stent-assisted coiling (CYSAC) is a promising method for treating challenging wide-neck bifurcation aneurysms, although it can be technically difficult.
- A study involving 37 patients treated with Y-stent-assisted coiling using LVIS EVO stents showed that a significant majority (83.8%) achieved excellent occlusion immediately after treatment, with high success rates maintained over an average follow-up of nearly 33 months.
- The researchers' "drill turn" technique for stent crossing was effective, leading to safe outcomes and stable occlusion rates, demonstrating the method's feasibility for treating these aneurysms.
Multicenter early United States feasibility study and periprocedural safety of LVIS EVO for the treatment of unruptured intracranial aneurysms.
J Neurointerv Surg
June 2024
Neurosurgery, Albany Medical Center, Albany, New York, USA
Background: Stent development has focused recently on low-profile, self-expandable stents compatible with 0.0165 inch microcatheters. The LVIS EVO is the second-generation version of the Low-Profile Visualized Intraluminal Support (LVIS) with improved visibility and resheathability.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!